Is Palantir Stock a Millionaire Maker?
Palantir (NASDAQ:PLTR) has shot upward over the last year and…
Sell
37
MMS Quote, Financials, Valuation and Earnings
Last price:
$67.25
Seasonality move
:
3.46%
Day range:
$65.50 - $67.09
52-week range:
$63.77 - $93.97
Dividend yield:
1.81%
P/E ratio:
14.26x
P/S ratio:
0.75x
P/B ratio:
2.28x
Volume:
550.4K
Avg. volume:
549.7K
1-year change:
-17.85%
Market cap:
$3.8B
Revenue:
$5.3B
EPS (TTM):
$4.65
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Maximus has 53.78% upside to fair value with a price target of $102.00 per share.
MMS vs. S&P 500
-
Over the past 5 trading days, Maximus has underperformed the S&P 500 by -4.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Maximus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Maximus has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Maximus reported revenues of $1.4B.
Earnings Growth
-
Maximus earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Maximus reported earnings per share of $0.69.
Enterprise value:
5.1B
EV / Invested capital:
--
Price / LTM sales:
0.75x
EV / EBIT:
10.82x
EV / Revenue:
0.94x
PEG ratio (5yr expected):
0.26x
EV / Free cash flow:
16.97x
Price / Operating cash flow:
13.57x
Enterprise value / EBITDA:
8.54x
Gross Profit (TTM):
$1.3B
Return On Assets:
7.01%
Net Income Margin (TTM):
5.28%
Return On Equity:
16.11%
Return On Invested Capital:
9.47%
Operating Margin:
6.19%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4.7B | $5B | $5.4B | $1.3B | $1.4B | |
| Gross Profit | $956.4M | $1.1B | $1.3B | $300.1M | $301.6M | |
| Operating Income | $308.1M | $327.5M | $467.8M | $107.5M | $86.8M | |
| EBITDA | $451.7M | $471.7M | $593.7M | $138.8M | $118M | |
| Diluted EPS | $3.09 | $3.02 | $4.65 | $1.04 | $0.69 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $986.8M | $1.1B | $1.3B | $1.1B | $1.2B | |
| Total Assets | $2.1B | $4.2B | $4.2B | $4B | $4.1B | |
| Current Liabilities | $547.4M | $710.8M | $746.2M | $658.4M | $678.9M | |
| Total Liabilities | $767.9M | $2.7B | $2.7B | $2.3B | $2.4B | |
| Total Equity | $1.3B | $1.5B | $1.6B | $1.7B | $1.6B | |
| Total Debt | $32.6M | $1.6B | $1.6B | $1.3B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $158.1M | $470.6M | $413.7M | $21.6M | -$80M | |
| Cash From Investing | -$63.4M | -$85.7M | -$130.9M | -$20.4M | -$22.3M | |
| Cash From Financing | -$132.2M | -$393.4M | -$312.3M | $28.4M | -$8.3M | |
| Free Cash Flow | $92.6M | $373.4M | $298.7M | -$639K | -$103M | |
MMS
Sector
Market Cap
$3.8B
$585.8M
Price % of 52-Week High
70.59%
72.48%
Dividend Yield
1.81%
0%
Shareholder Yield
--
2.44%
1-Year Price Total Return
-17.85%
-7.41%
Beta (5-Year)
0.615
0.782
Dividend yield:
1.81%
Annualized payout:
$1.20
Payout ratio:
25.59%
Growth streak:
1 years
Technicals
8-day SMA
Sell
Level
$67.65
200-day SMA
Sell
Level
$79.45
Bollinger Bands (100)
Sell
Level
66.76 - 74.84
Chaikin Money Flow
Buy
Level
51.3M
20-day SMA
Sell
Level
$67.77
Relative Strength Index (RSI14)
Sell
Level
41.87
ADX Line
Sell
Level
10.91
Williams %R
Neutral
Level
-79.9517
50-day SMA
Sell
Level
$67.65
MACD (12, 26)
Sell
Level
-0.31
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
59.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6957)
Buy
CA Score
(Annual)
Level (0.2818)
Buy
Beneish M-Score
(Annual)
Level (-2.7142)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.5225)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.
Stock Forecast FAQ
In the current month, MMS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MMS average analyst price target in the past 3 months is $102.00.
-
Where Will Maximus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Maximus share price will rise to $102.00 per share over the next 12 months.
-
What Do Analysts Say About Maximus?
Analysts are divided on their view about Maximus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Maximus is a Sell and believe this share price will drop from its current level to $90.00.
-
What Is Maximus's Price Target?
The price target for Maximus over the next 1-year time period is forecast to be $102.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MMS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Maximus is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of MMS?
You can purchase shares of Maximus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Maximus shares.
-
What Is The Maximus Share Price Today?
Maximus was last trading at $67.25 per share. This represents the most recent stock quote for Maximus. Yesterday, Maximus closed at $66.33 per share.
-
How To Buy Maximus Stock Online?
In order to purchase Maximus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
62
RGC alert for May 2
Regencell Bioscience Holdings [RGC] is down 18.18% over the past day.
Buy
65
MYRG alert for May 2
MYR Group [MYRG] is up 2.32% over the past day.
Sell
35
FTAI alert for May 2
FTAI Aviation [FTAI] is up 4.82% over the past day.
